Published: Jan 01, 2021, 04:15 IST | Updated: Jan 01, 2021, 04:15 IST
Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.